Limitations
Our study is limited by its observational design and its dependence on claims datasets, and inaccuracies in coding and claims may be possible. Nonetheless, such claims data are often used to assess AF epidemiology, in relation to risk factors and healthcare costs. As with observational cohorts, the possibility of residual confounding remains.